# Clinical Trial Landscape: 15_ovarian_brca1_platinum_sensitive

*Generated: 2026-01-05 18:34:44*

## Summary

- **Total Trials**: 100
- **Flagged for Review**: 0
- **Search Terms Used**: 9

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 2 | 25 | █████ 25.0% |
| Phase 1 | 23 | ████ 23.0% |
| Unknown | 22 | ████ 22.0% |
| Not Applicable | 12 | ██ 12.0% |
| Phase 1/Phase 2 | 12 | ██ 12.0% |
| Phase 3 | 5 | █ 5.0% |
| Early Phase 1 | 1 |  1.0% |

## Status Distribution

- **Recruiting**: 97 (97.0%)
- **Enrolling by invitation**: 2 (2.0%)
- **Not yet recruiting**: 1 (1.0%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| National Cancer Institute (NCI) | 11 |
| M.D. Anderson Cancer Center | 5 |
| University Health Network, Toronto | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Dana-Farber Cancer Institute | 3 |
| AbbVie | 3 |
| Mayo Clinic | 3 |
| University of Nebraska | 2 |
| McGill University | 2 |
| Georgetown University | 2 |
| NRG Oncology | 2 |
| Genmab | 2 |
| Emory University | 2 |
| Northwestern University | 1 |
| Columbia University | 1 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Biospecimen Collection | 12 |
| Olaparib | 10 |
| Computed Tomography | 9 |
| Bevacizumab | 8 |
| Magnetic Resonance Imaging | 7 |
| Pembrolizumab | 6 |
| Paclitaxel | 6 |
| Abemaciclib | 5 |
| Biopsy Procedure | 5 |
| Biopsy | 4 |
| Multigated Acquisition Scan | 3 |
| Gemcitabine | 3 |
| Niraparib | 3 |
| Carboplatin | 3 |
| Blood draw and questionnaires | 2 |
| MRI | 2 |
| Palbociclib | 2 |
| Talazoparib | 2 |
| Futibatinib | 2 |
| Letrozole | 2 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 90 |
| Canada | 18 |
| Spain | 13 |
| Australia | 10 |
| France | 10 |
| United Kingdom | 10 |
| Belgium | 9 |
| Italy | 8 |
| South Korea | 8 |
| Japan | 6 |
| Israel | 5 |
| Puerto Rico | 5 |
| Netherlands | 4 |
| Norway | 3 |
| Poland | 3 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| BRCA1 germline mutation | manual | 1.0 |
| ovarian cancer | manual | 1.0 |
| BRCA1 germline mutation ovarian cancer | manual | 1.0 |
| BRCA1 germline mutation high-grade serous ovarian cancer | llm | 0.9 |
| BRCA1 mutation ovarian cancer | llm | 0.9 |
| high-grade serous ovarian cancer | llm | 0.8 |
| ovarian carcinoma | llm | 0.8 |
| BRCA1 pathogenic variant | llm | 0.9 |
| BRCA1 | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT06654050](https://clinicaltrials.gov/study/NCT06654050) | Phase 2 | Not yet recruiting | National Cancer Inst... | Phase II Study of Alrizomadlin (APG... |
| [NCT06971744](https://clinicaltrials.gov/study/NCT06971744) | Phase 2 | Recruiting | Medical University o... | Autophagy Maintenance (AUTOMAIN) Th... |
| [NCT06910657](https://clinicaltrials.gov/study/NCT06910657) | Phase 1 | Recruiting | ViroMissile, Inc. | A First-in-human, Phase I, Multi-ce... |
| [NCT06630325](https://clinicaltrials.gov/study/NCT06630325) | Phase 2 | Recruiting | OHSU Knight Cancer I... | Serial Measurements of Molecular an... |
| [NCT06892275](https://clinicaltrials.gov/study/NCT06892275) | Not Applicable | Recruiting | Georgetown Universit... | The FYI on MRI: A Multilevel Decisi... |
| [NCT06843447](https://clinicaltrials.gov/study/NCT06843447) | Phase 1/Phase 2 | Recruiting | Merck Sharp & Dohme ... | A Phase 1b/2 Open-label, Multicente... |
| [NCT06799065](https://clinicaltrials.gov/study/NCT06799065) | Phase 1 | Recruiting | Accent Therapeutics | A Phase 1/2, Open-Label, Dose-Escal... |
| [NCT06580314](https://clinicaltrials.gov/study/NCT06580314) | Phase 3 | Recruiting | NRG Oncology | A Phase III Trial of One vs. Two Ye... |
| [NCT06619236](https://clinicaltrials.gov/study/NCT06619236) | Phase 3 | Recruiting | Genmab | A Phase 3 Randomized, Open-label St... |
| [NCT06760507](https://clinicaltrials.gov/study/NCT06760507) | Not Applicable | Recruiting | Emory University | Evaluating an Evidence-Based Family... |
| [NCT06660654](https://clinicaltrials.gov/study/NCT06660654) | Phase 2 | Recruiting | Daiichi Sankyo | REJOICE-PanTumor01: A Phase 2, Mult... |
| [NCT06677190](https://clinicaltrials.gov/study/NCT06677190) | Phase 2 | Recruiting | Dana-Farber Cancer I... | A Phase II Trial of Belzutifan in P... |
| [NCT06732336](https://clinicaltrials.gov/study/NCT06732336) | Phase 1/Phase 2 | Recruiting | Centre de recherche ... | HER2-PET Imaging Using 89Zr-trastuz... |
| [NCT06639074](https://clinicaltrials.gov/study/NCT06639074) | Phase 2 | Recruiting | Mayo Clinic | MC1963 Folate Receptor Alpha Dendri... |
| [NCT06555744](https://clinicaltrials.gov/study/NCT06555744) | Phase 1 | Recruiting | Zymeworks BC Inc. | A Phase 1, Open-label, Multicenter ... |
| [NCT05610735](https://clinicaltrials.gov/study/NCT05610735) | Phase 1/Phase 2 | Recruiting | Sham Sunder Kakar | Combination Therapy With Liposomal ... |
| [NCT06476808](https://clinicaltrials.gov/study/NCT06476808) | Phase 1 | Recruiting | Bristol-Myers Squibb | A Phase 1/1b First-in-human Study o... |
| [NCT06268665](https://clinicaltrials.gov/study/NCT06268665) | Phase 2 | Recruiting | Eve Rodler | A Randomized Trial of Tart Cherry J... |
| [NCT06297525](https://clinicaltrials.gov/study/NCT06297525) | Phase 1 | Recruiting | Step Pharma, SAS | An Open-Label, Phase 1 Study to Eva... |
| [NCT06365853](https://clinicaltrials.gov/study/NCT06365853) | Phase 2 | Recruiting | AbbVie | A Randomized Phase 2 Study of Ocula... |
| [NCT06504147](https://clinicaltrials.gov/study/NCT06504147) | Phase 2 | Recruiting | Oncoinvent AS | A Phase 2, Randomised, Open Label, ... |
| [NCT06451497](https://clinicaltrials.gov/study/NCT06451497) | Phase 1 | Recruiting | Zumutor Biologics In... | Phase 1 Dose Escalation Trial of ZM... |
| [NCT06395519](https://clinicaltrials.gov/study/NCT06395519) | Phase 1/Phase 2 | Recruiting | 858 Therapeutics, In... | A Study of PARG Inhibitor ETX-19477... |
| [NCT06290193](https://clinicaltrials.gov/study/NCT06290193) | Phase 2 | Recruiting | Memorial Sloan Kette... | A Prospective Randomized Trial of A... |
| [NCT06234423](https://clinicaltrials.gov/study/NCT06234423) | Phase 1 | Recruiting | OnCusp Therapeutics,... | A Phase 1, First-in-Human Study of ... |
| [NCT06177171](https://clinicaltrials.gov/study/NCT06177171) | Phase 1 | Recruiting | Pamela Munster | A Phase I/Ib Study of Olaparib and ... |
| [NCT05950464](https://clinicaltrials.gov/study/NCT05950464) | Phase 1 | Recruiting | National Cancer Inst... | A Phase 1B Study of Combination ATR... |
| [NCT06188520](https://clinicaltrials.gov/study/NCT06188520) | Phase 1/Phase 2 | Recruiting | AstraZeneca | A Phase I/IIa, First-in-human, Open... |
| [NCT05799274](https://clinicaltrials.gov/study/NCT05799274) | Phase 1 | Recruiting | Radiopharm Theranost... | Characterizing the Radiochemical an... |
| [NCT05998135](https://clinicaltrials.gov/study/NCT05998135) | Phase 2 | Recruiting | Emory University | Phase II Clinical Trial Repurposing... |
| [NCT05819853](https://clinicaltrials.gov/study/NCT05819853) | Phase 3 | Recruiting | University of Colora... | Role of Semaglutide in Restoring Ov... |
| [NCT05902988](https://clinicaltrials.gov/study/NCT05902988) | Phase 1/Phase 2 | Recruiting | Volastra Therapeutic... | A Phase I/II Study of VLS-1488 (an ... |
| [NCT05920798](https://clinicaltrials.gov/study/NCT05920798) | Phase 1/Phase 2 | Recruiting | Mayo Clinic | MC220601, Folate Receptor Alpha Den... |
| [NCT05961124](https://clinicaltrials.gov/study/NCT05961124) | Phase 2 | Recruiting | Sunnybrook Health Sc... | A Phase II, Single-Arm Trial Assess... |
| [NCT05636111](https://clinicaltrials.gov/study/NCT05636111) | Phase 1 | Recruiting | M.D. Anderson Cancer... | Phase 1b of Lurbinectedin in Combin... |
| [NCT05985655](https://clinicaltrials.gov/study/NCT05985655) | Phase 1/Phase 2 | Recruiting | Exscientia AI Ltd., ... | A Phase 1/2 Open-label Multicenter ... |
| [NCT05910294](https://clinicaltrials.gov/study/NCT05910294) | Not Applicable | Recruiting | Memorial Sloan Kette... | Randomized Pilot Prevention Trial t... |
| [NCT05694715](https://clinicaltrials.gov/study/NCT05694715) | Phase 1 | Recruiting | University of Califo... | Combination Therapy of Niraparib an... |
| [NCT05684965](https://clinicaltrials.gov/study/NCT05684965) | Phase 1/Phase 2 | Recruiting | Xilio Development, I... | A First-in-Human, Multicenter, Phas... |
| [NCT05554328](https://clinicaltrials.gov/study/NCT05554328) | Phase 2 | Recruiting | National Cancer Inst... | A Randomized Trial of Selumetinib a... |
| [NCT05787587](https://clinicaltrials.gov/study/NCT05787587) | Phase 1 | Recruiting | IDEAYA Biosciences | A Study of PARG Inhibitor IDE161 in... |
| [NCT05827614](https://clinicaltrials.gov/study/NCT05827614) | Phase 1 | Recruiting | Boundless Bio | An Open-Label, Multicenter, First-i... |
| [NCT05065021](https://clinicaltrials.gov/study/NCT05065021) | Phase 2 | Recruiting | University Health Ne... | Re-VOLVE: A Phase II Clinical Trial... |
| [NCT05512208](https://clinicaltrials.gov/study/NCT05512208) | Phase 2 | Recruiting | University of Oklaho... | A Phase 2 Study of VS-6766 (Dual RA... |
| [NCT05527184](https://clinicaltrials.gov/study/NCT05527184) | Phase 1 | Recruiting | AbbVie | A Phase 1, First-in-Human, Open-Lab... |
| [NCT05625529](https://clinicaltrials.gov/study/NCT05625529) | N/A | Recruiting | Biological Dynamics | Exoluminate Study: Observational Re... |
| [NCT05579366](https://clinicaltrials.gov/study/NCT05579366) | Phase 1/Phase 2 | Recruiting | Genmab | Phase 1/2 Study of Rina-S in Patien... |
| [NCT05649072](https://clinicaltrials.gov/study/NCT05649072) | Not Applicable | Recruiting | M.D. Anderson Cancer... | Identifying Underserved Individuals... |
| [NCT05327010](https://clinicaltrials.gov/study/NCT05327010) | Phase 2 | Recruiting | National Cancer Inst... | Phase 2 Trial of the Combination of... |
| [NCT05281471](https://clinicaltrials.gov/study/NCT05281471) | Phase 3 | Recruiting | Genelux Corporation | A Randomized Phase 3 Study Assessin... |

*... and 50 more trials (see trials.csv for full list)*
